FCF YoY
-21.24%
OCF YoY
-11.78%
Capex YoY
+69.07%
FCF Conversion Δ
-9.6 pp
Free cash flow bridge for Amgen (AMGN) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: −$2.32B
FCF bridge breakdown for Amgen (AMGN) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $10.91B | — |
| Operating Cash Flow | −$1.44B | -61.9% |
| Capital Expenditure | −$882.00M | -38.1% |
| Free Cash Flow | $8.60B | — |
- Prior Free Cash Flow$10.91B
- Operating Cash Flow−$1.44B
- Capital Expenditure−$882.00M
- Free Cash Flow$8.60B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement